# GH Research PLC (GHRS): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for GH Research PLC (GHRS) is 29/100, ranked against 24,000+ stocks in 35 markets (Quality 38, Value 26, Momentum 52, each scored against its sector).

- StockRank: 29/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 38, Value 26, Momentum 52: each a 0-100 percentile within the stock's sector.
- Position: #19,191 overall, #1,656 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 20.02 USD on 12 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/GHRS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker